Central Department of Biotechnology

Kirtipur, Kathmandu


Professor
Prof.Dr. Rajani Malla
ACADEMIC

Female
rajani.malla@cdbt.tu.edu.np

No Data Found !!

Ph.D.  Jawaharlal Nehru University, New- Delhi, India

Asst. Lecturer Department of Microbiology since Oct. 1990 to June 1997

Microbiologist. Research Centre for Applied Science and Technology, Kirtipur, Jan. 1994 to Jan.1995

Lecturer, Department of Microbiology, Tri-Chandra college, since June 1997

Head, Department of Microbiology Tri-Chandra college since Aug. 30, 1996 to July 30, 2001

Worked as Co-Coordinator establishment of  Master in biotechnology, TU. 2006

Head, Central Department of Biotechnology, 2012-2016

Asst. Lecturer Department of Microbiology since Oct. 1990 to June 1997

Microbiologist. Research Centre for Applied Science and Technology, Kirtipur, Jan. 1994 to Jan.1995

Lecturer, Department of Microbiology, Tri-Chandra college, since June 1997

Head, Department of Microbiology Tri-Chandra college since Aug. 30, 1996 to July 30, 2001

Worked as Co-Coordinator establishment of  Master in biotechnology, TU. 2006

Head, Central Department of Biotechnology, 2012-2016

Prospects of Indole derivatives as methyl transfer inhibitors: antimicrobial resistance managers. Suprim ThaSapana ShakyaRajani Malla & Pramod AryalBMC Pharmacology and Toxicology volume  Article number: 33 (2020) 

Complete Genome Sequence of Myophage Ec_Makalu_002, Which Infects Uropathogenic Escherichia coli. January 2020. Microbiology Resource Announcements 9(5) DOI:10.1128/MRA.01530-19

Therapeutic Efficacy of Bacteriophage Therapy to Treat Carbapenem Resistant Klebsiella Pneumoniae in Mouse Model. J Nepal Health Res Counc 2021 Jan-Mar;19(50): 76-82        

Pharmacokinetics and Pharmacodynamics of a Novel Virulent Klebsiella Phage Kp_Pokalde_002 in a Mouse Model. Frontiers in Cellular and Infection microbiology. Aug. 2021

Maculosin, a nontoxic antioxidant compound isolated from Streptomyces sp. KTM18 , 2021. Pharmaceutical Biology, 59:1, 933-936, DOI: 10.1080/13880209.2021.1946091

Genome report of three novel bacteriophages targeting different multidrug resistant clinical isolates (Escherichia, Klebsiella and Salmonella) from Enterobacteriaceae family. February 2022, DOI:10.21203/rs.3.rs-1363627/v1

Isolation and Characterization of Lytic Bacteriophage Against Multi-drug Resistant Pseudomonas aeruginosa. .Journal of Nepal Health Research Council.2022. 19(04):717-724. 10.33314/jnhrc.v19i04.3837

Genomic characterization of three bacteriophages targeting multidrug resistant clinical isolates of Escherichia, Klebsiella and Salmonella.June 2022. Archives of Microbiology 204(6). 10.1007/s00203-022-02948-0

Spontaneous mutations and reversions in the tail spike protein of a phage Kp_Pokalde_001 switch the plaque morphology. Conference Paper. Oct 2022